In the Netherlands, approximately 600 children are diagnosed with cancer every year. Due to improvement of treatment, combining surgery, multi-agent chemotherapy, and radiotherapy, in addition to remarkable advances in supportive care, survival has increased substantially over the last decades, leading to a rapidly growing cohort of childhood cancer survivors. Approximately 7000 long-term survivors of childhood cancer are living in the Netherlands nowadays.

,
The studies described in this thesis were financially supported by Kinderen Kankervrij (KiKa) Foundation. Printing of this thesis was kindly supported by: J.E. Jurriaanse Stichting, Goodlife Healthcare, sanofi-aventis BV, Novartis Pharma BV, Pfizer BV, Ipsen pharmaceutica BV, Novo Nordisk BV, ProStrakan Pharma BV.
A-J. van der Lely (Aart-Jan)
Erasmus University Rotterdam
hdl.handle.net/1765/41239
Erasmus MC: University Medical Center Rotterdam

Blijdorp, K. (2013, September 11). Determinants & Sequelae of Altered Body Composition in Childhood Cancer Survivors. Retrieved from http://hdl.handle.net/1765/41239